Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice
2018 · Science · 1,389 citations
https://doi.org/10.1126/science.aao4227
M
Mario A. Shields
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
87
Papers
2.7K
Citations
18
h-index
22
i10-index
Mario A. Shields is an academic researcher from Stony Brook School. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Cancer Cells and Metastasis & Cancer Immunotherapy and Biomarkers. The author has an h-index of 18, co-authored 74 publications.
ORCID: 0000-0002-3562-9875Papers by this author
worksInterplay between β1-Integrin and Rho Signaling Regulates Differential Scattering and Motility of Pancreatic Cancer Cells by Snail and Slug Proteins
2012 · Journal of Biological Chemistry · 62 citations
https://doi.org/10.1074/jbc.m111.308940
Gα13 loss in Kras/Tp53 mouse model of pancreatic tumorigenesis promotes tumors susceptible to rapamycin
2022 · Cell Reports · 13 citations
https://doi.org/10.1016/j.celrep.2022.110441
Targeting BCL2 with Venetoclax Enhances the Efficacy of the <i>KRAS</i> G12D Inhibitor MRTX1133 in Pancreatic Cancer
2024 · Cancer Research · 13 citations
https://doi.org/10.1158/0008-5472.can-23-3574
Figure S4 from Targeting BCL2 with Venetoclax Enhances the Efficacy of the <i>KRAS</i><sup>G12D</sup> Inhibitor MRTX1133 in Pancreatic Cancer
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27603378
Figure S2 from Targeting BCL2 with Venetoclax Enhances the Efficacy of the <i>KRAS</i><sup>G12D</sup> Inhibitor MRTX1133 in Pancreatic Cancer
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27603387
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat